Side-by-side comparison of AI visibility scores, market position, and capabilities
FY2024 Revenue: $372.8B (+4.2% YoY) | Net income: $4.6B (down from $8.4B) | Operating income: $8.5B (-38% YoY) | Q4 2024: $97.7B | Healthcare benefits segment challenged
CVS Health is an integrated healthcare company operating retail pharmacies, pharmacy benefit management services, health clinics, and specialty pharmacy offerings across the United States. The company serves patients, health plan members, and healthcare providers seeking accessible, affordable prescription medications, over-the-counter products, and health services. CVS Health differentiates itself through its extensive retail footprint with convenient neighborhood locations, MinuteClinic walk-in health services, integrated pharmacy benefits through CVS Caremark, and digital health tools that improve medication adherence and care coordination.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.